Meta-Analysis of HER2-Enriched Subtype Predicting the Pathological Complete Response Within HER2-Positive Breast Cancer in Patients Who Received Neoadjuvant Treatment

Meta-Analysis of HER2-Enriched Subtype Predicting the Pathological Complete Response Within HER2-Positive Breast Cancer in Patients Who Received Neoadjuvant Treatment

BackgroundThis meta-analysis aimed to better elucidate the predictive value of human epidermal growth factor receptor 2 (HER2)-enriched subtype of pathological complete response (pCR) rate within HER2-positive breast cancer patients receiving neoadjuvant treatment.MethodsWe identified prospective tr...

Full description

Bibliographic Details
Main Authors: Guoshuang Shen, Fuxing Zhao, Xingfa Huo, Dengfeng Ren, Feng Du, Fangchao Zheng, Jiuda Zhao
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-07-01
Series:Frontiers in Oncology
Subjects:
human epidermal growth factor receptor 2 (HER2)-enriched subtype
HER2-postive breast cancer
neoadjuvant treatment
pathologic complete response
meta-analysis
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.632357/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.632357/full

Similar Items